Choom Enhances Retail Strategy With Expansion Into Medical Cannabis Channel

Choom™ (CSE: CHOO) (OTCQB: CHOOF) (CHOOM PROFILEmade a big deal today to strengthen their retail strategy by obtaining Clarity Cannabis Medical Centres. 

We have talked a lot about the strength of the recreational retail strategy, and this deal goes them even closer to being the premium cannabis retail business in Canada.

They have 45 opportunities in the rec area, and with this deal they add a telemedicine platform that is proprietary and 5 more medical centers. 

This is a big deal marijuana has been legal in Canada for a while and already has a very substantial demand, and now Choom has a footprint in recreational outlets and outlets. 

An additional reason why we believe Choom is a hidden breakout inventory that’s well positioned to be the leader in the next leg of the bud boom. 


Choom Expands into Medical Cannabis Channel with the Acquisition of Clarity Cannabis Medical Centres

Choom™ (CSE: CHOO) (OTCQB: CHOOF) an emerging adult use cannabis company that has secured among the largest national retail networks in Canada, is pleased to announce it has acquired Clarity Cannabis Medical Centre Inc. and affiliates doing business as Clarity Medical Centres.

Chris Bogart, President & CEO says,”Our goal is to build a dominant national cannabis retail manufacturer. The acquisition of Clarity Medical Centres allows the entire cannabis market, beyond just the adult use channel to be serviced by Choom. Since cannabis becomes more widely recognized as an alternative to pharmaceuticals, increasingly, patients with medical conditions will require professional medical advice on the advantages and best use of cannabis as a treatment.”
The acquisition includes five new medical centers together with a proprietary telemedicine platform that provides important education, accessibility and expertise for referring patients in the use of cannabis for medical purposes. The Clarity Medical Centres approach streamlines the process of registering with a producer that is certified and makes it simple for patients to get cannabis products that are legal in Canada.
There are medical conditions that may benefit from cannabis when it comes to treating several health issues including chronic pain, PTSD, seizures, tremors, and general anxiety. The group of cannabis of clarity trained general and specialist doctors, nurses and coaches all work together to ensure patients get optimal care. The clinics will provide education as an alternative to pharmaceuticals to patients on the use of medical cannabis products. 
Under the leadership of Dr. Jean Paul Lim, an internal medicine and complex care pro, Clarity Medical Centres intend to study and monitor the effects of medicinal cannabis use. Clarity Medical Centres may use a patient-focused, research-based, multidisciplinary approach, where Dr. Lim hopes to violate cannabis misconceptions and build scientific evidence through the collection of patient data points around cannabis as an effective treatment.
As part of the trade, Choom can get medical expertise from the clinics and leverage key learnings from the medical side to offer customer insights for our adult use channel. The Clarity medical practice model is scalable and transferable across the cannabis area that is fast growing, both domestically and internationally adding an important revenue stream that is retail to rsquo & Choom;s use strategy that is mature.
Choom™ is an emerging adult use cannabis company that has secured among the largest retail networks in Canada. Hawaii’s & ldquo; rdquo & Choom Gang inspire the Choom brand;–a group of friends in Honolulu during the 1970’s who loved to smoke weed–or as the natives called it, “Choom”. Evoking the spirit of the first Choom Gang, our brand caters to the Canadian use marketplace with cultivating & lsquo; Good Times with Good Friends & rsquo’s ethos;. Choom™ is focused on delivering an customer experience offering a diversity of brands for Canadians across a nationwide retail community. 

Please see complete disclaimers in applicable to all content provided by TSI, wherever printed or re-published:

Disclaimer: This release/advertorial is a commercial advertisement and is for general information purposes only. This release/advertorial does not constitute solicitation or an offer to buy or sell any securities or individualized investment advice. This is a advertisement, meaning it is an informational advertising piece that is paid. (TSI) makes no recommendation that the securities of the companies profiled or discussed on this site ought to be bought, sold or held by audiences that learn of the profiled companies through our site. Please review all investment decisions. TSI receives payments ranging to publish and/or distribute ads on behalf of a business. Any sums that are surplus are retained by TSI after expenses as its compensation. and its owners, owners and affiliates may benefit from any increase in the share prices of the profiled companies. may be compensated for services using alternatives or free-trading shares. and/or its owners, operators and affiliates could be selling shares of stock in the exact same time the profile (or other information) has been disseminated to prospective investors; will not advise when it or its affiliates decide to sell. All investment decisions must be made by investors based on their judgment of the securities that are specific and the market.
This advertorial contains forward-looking statements which involve uncertainties and risks. This advertorial contains or incorporates by reference forward-looking statements, including certain information with respect to strategies and plans of the company. Therefore, any statements contained herein or incorporated herein may be deemed to be forward-looking statements. Without limiting the foregoing, the words “believe(s),” “expect (s),” “plan(s),” “anticipate (s),” “job (s),” “will,” “make,” “told,” “can,” “might,” and similar expressions are intended to identify forward-looking statements. There are a number of important factors that could cause actual events or actual results of the company to differ materially from these indicated by such forward-looking statements. Such statements include, without limitation, statements concerning future operating revenues, financing, business trends, business and expenses. There can be no assurance that these expectations will prove to be right. Investors are cautioned that any forward-looking statements made by the business, or contained within this advertorial are not guarantees of future performance, and that the issuer’s actual results may differ materially from those set forth in the forward-looking statements. We undertake no obligation to update any statements except as required by law. Differences in results may be caused by various factors including, but not limited to, the company’s ability to be able to successfully complete planned financing arrangements, to successfully market its products in competitive businesses or to effectively implement its business plan or strategies. To reiterate, data presented in this advertorial contains &ldquo statements. ” Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact and may be “forward-looking statements. More information on the company may be found in where subscribers can review all public filings submitted by the business. is not a certified financial analyst or accredited in the securities industry in any manner. The information within this advertorial is opinion and may not be current, accurate or complete and has been compensated for, so this may create a conflict of interest.

Posted in: News

Comments are closed.